BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 235163)

  • 1. Specific unresponsiveness to skin allografts in mice. IV. Immunological reactivity of mice treated with liver extracts, Bordetella pertussis, and antilymphocyte serum.
    Brooks CG; Brent L; Kilshaw PJ; New RR; Pinto M
    Transplantation; 1975 Feb; 19(2):134-44. PubMed ID: 235163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum.
    Kilshaw PJ; Brent L; Thomas AV
    Transplantation; 1974 Jan; 17(1):57-69. PubMed ID: 4148889
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of specific unresponsiveness with the aid of Bordetella pertussis.
    Brent L; Pinto M
    Transplant Proc; 1973 Mar; 5(1):697-701. PubMed ID: 4348708
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
    Maki T; Gottschalk R; Wood ML; Monaco AP
    J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A; Dy M; Thomson N; Hamburger J
    J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergy among thymocytes and peripheral lymph node cells in the in vitro generation of lymphocytes cytotoxic to alloantigens.
    Tigelaar RE; Feldmann M
    Transplant Proc; 1973 Dec; 5(4):1711-5. PubMed ID: 4272825
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenetic disparity and graft-versus-host reactions.
    Bach ML; Bach FH
    Semin Hematol; 1974 Jul; 11(3):291-303. PubMed ID: 4151845
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 11. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of allograft reactivity in vitro and in vivo, by Fab fragments obtained from ALG.
    Gallagher MT; Richie ER; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):869-72. PubMed ID: 4144466
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion.
    Wood ML; Gozzo JJ; Heppner G; Monaco AP
    Transplant Proc; 1972 Sep; 4(3):383-9. PubMed ID: 4263511
    [No Abstract]   [Full Text] [Related]  

  • 15. IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice.
    Donckier V; Abramowicz D; Bruyns C; Florquin S; Vanderhaeghen ML; Amraoui Z; Dubois C; Vandenabeele P; Goldman M
    J Immunol; 1994 Sep; 153(6):2361-8. PubMed ID: 8077653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immune responses in vitro. V. A comparative study of in vitro immunogenicity of splenic lymphocytes, neoplastic lymphoid cells and fibroblats.
    Wagner H; Wyss C
    Eur J Immunol; 1973 Sep; 3(9):549-55. PubMed ID: 4271926
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic antibodies and lymphocytes induced by orthotopic tooth bud allografts in mice.
    Riviere GR
    J Immunol; 1974 Feb; 112(2):776-82. PubMed ID: 4205208
    [No Abstract]   [Full Text] [Related]  

  • 18. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neonatally and adoptively induced transplantation tolerance in mice.
    Hasek M; Holán V; Chutná J
    Folia Biol (Praha); 1980; 26(3):167-75. PubMed ID: 6448173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.